Advertisement

Necrotizing Soft Tissue Infections (NSTI)

  • Stefania CimbanassiEmail author
  • Osvaldo Chiara
Chapter

Abstract

Necrotizing soft tissue infections (NSTI) are a rare condition characterized by rapid but subtle onset of spreading inflammation and necrosis starting from the fascia, involving muscles and subcutaneous fat, with subsequent necrosis of the overlying skin. Irrespective of its etiology, both polymicrobial and monomicrobial, this pathology warrants an aggressive multidisciplinary strategy, encompassing broad-spectrum antibiotic therapy, extensive surgical debridement, critical care, and postsurgery hyperbaric oxygen therapy (HBO), in order to limit the spread of systemic inflammatory response and to reduce mortality. This chapter provides an extensive overview of the microbiology, pathophysiology, and diagnostic and therapeutic strategies to be considered in case of necrotizing soft tissue infections. The clinical scenario at the end of the chapter helps the reader to practically apply in a real setting all the suggested diagnostic and therapeutic tricks. This is an updated, easy-to-use work of reference for all clinicians, residents, and caregivers who may be involved in the management of patients suffering from NSTI.

References

  1. 1.
    Lancerotto L, Tocco I, Salmaso R, Vindigni V, Bassetto F. Necrotizing fasciitis: classification, diagnosis, and management. J Trauma. 2012;72:560–6.CrossRefGoogle Scholar
  2. 2.
    Sarani B, Strong M, pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208:279–88.CrossRefGoogle Scholar
  3. 3.
    Shiroff AM, Herlitz GN, Gracias VH. Necrotizing soft tissue infections. J Int Care Med. 2014;29:138–44.CrossRefGoogle Scholar
  4. 4.
    Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51:344–62.CrossRefGoogle Scholar
  5. 5.
    Salcido R. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007;20:288–93.CrossRefGoogle Scholar
  6. 6.
    Liu YM, Chi CY, Ho MW. Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect. 2005;38:430–5.PubMedGoogle Scholar
  7. 7.
    Tsai YH, Huang TJ, Hsu RW. Necrotizing soft tissue infections and primary sepsis caused by Vibrio vulnificus and Vibrio cholerae no-O1. J Trauma. 2009;66:899–905.CrossRefGoogle Scholar
  8. 8.
    Kao LS, Lew DF, Arab SN, et al. Local variation in the epidemiology, microbiology, and outcome of necrotizing soft tissue infections: a multicenter study. Am J Surg. 2011;202:139–45.CrossRefGoogle Scholar
  9. 9.
    Low DE, McGeer A. Skin and soft tissue infections: necrotizing fasciitis. Curr Opin Infect Dis. 1998;11:119–23.CrossRefGoogle Scholar
  10. 10.
    Wong CH, Wang YS. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis. 2005;18:101–6.CrossRefGoogle Scholar
  11. 11.
    Seal DV. Necrotizing fasciitis. Curr Opin Infect Dis. 2001;142:127–32.CrossRefGoogle Scholar
  12. 12.
    Seal DV, hay RJ, Middleton KR. Skin and wound infection: investigation and treatment in practice. London, UK: Martin Dunitz; 2000.Google Scholar
  13. 13.
    Wall D, Kleain S, Black S, de Virgilio C. A simple model to help distinguish necrotizing from non-necrotizing soft-tissue infections. Am J Surg. 2000;191:227–31.CrossRefGoogle Scholar
  14. 14.
    Wall D, de Virgilio C, Black S, Klein S. Objective criteria may assist in distinguishing necrotizing fasciitis from non-necrotizing soft-tissue infections. Am J Surg. 2000;179:17–21.CrossRefGoogle Scholar
  15. 15.
    Wong C, Khin L, Heng K, Tan K, Low C. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft-tissue infections. Crit Care Med. 2004;32:1535–41.CrossRefGoogle Scholar
  16. 16.
    Zacharias N, Velmahos GC, Salama A, et al. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010;145:452–5.CrossRefGoogle Scholar
  17. 17.
    Kim KT, Kim YJ, Lee W, et al. Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectios fasciitis with MR imaging? Radiology. 2011;259:816–24.CrossRefGoogle Scholar
  18. 18.
    Yen ZS, Wang HP, Ma HM, Chen SC, Chen WJ. Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med. 2002;9:1448–51.CrossRefGoogle Scholar
  19. 19.
    Childers BJ, Potyondy LD, Nachreiner R, et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg. 2002;68:109–16.PubMedGoogle Scholar
  20. 20.
    Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44:705–10.CrossRefGoogle Scholar
  21. 21.
    Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85:1454–60.CrossRefGoogle Scholar
  22. 22.
    Majeski JA, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J. 1997;90:1065–8.CrossRefGoogle Scholar
  23. 23.
    Estrada O, Martinez I, Del Bas M, Salvans S, Hidalgo LA. Rectal diversion without colostomy in Fournier’s gangrene. Tech Coloproctol. 2009;13:157–9.CrossRefGoogle Scholar
  24. 24.
    Ozturk E, Ozquc H, Ylmazlar T. The use of vacuum-assisted closure therapy in the management of Fournier’s gangrene. Am J Surg. 2009;197:660–5.CrossRefGoogle Scholar
  25. 25.
    Sartelli M, Malangoni MA, May KA, et al. World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg. 2014;9:57–74.CrossRefGoogle Scholar
  26. 26.
    Angus DC, Van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51.CrossRefGoogle Scholar
  27. 27.
    Tiipana EM, hamunen K, Kontinen VK, kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg. 2007;104:1545–56.CrossRefGoogle Scholar
  28. 28.
    Darabi K, Abdel-Wahab O, Dzik WH. Current usage of intravenous immunoglobulin and the rationale behind it: the Massachusetts General Hospital data and the review of the literature. Transfusion. 2006;46:741–53.CrossRefGoogle Scholar
  29. 29.
    Schrage B, Duan G, Yang LP, Fraser JD, Proft T. Different preparations of intravenous immunoglobulin vary their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome. Clin Infect Dis. 2006;43:743–6.CrossRefGoogle Scholar
  30. 30.
    Mulla ZD. Hyperbaric oxygen in necrotizing fasciitis. Plast Reconstr Surg. 2008;122:1984–5.CrossRefGoogle Scholar
  31. 31.
    Hassan Z, Mullins RF, Friedman BC, et al. Treating necrotizing fasciitis with or without hyperbaric oxygen therapy. Undersea Hyperb Med. 2010;37:115–23.PubMedGoogle Scholar
  32. 32.
    George ME, Rueth NM, Skarda DE, et al. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infections. Surg Infect. 2009;10:21–3.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Trauma Team and Emergency SurgeryNiguarda Trauma Center, AAST Grande Ospedale Metropolitano NiguardaMilanItaly

Personalised recommendations